NCT01870505 2024-12-09BYL719 Plus Letrozole or Exemestane for Patients With Hormone-Receptor Positive Locally-Advanced Unresectable or Metastatic Breast CancerMemorial Sloan Kettering Cancer CenterPhase 1 Completed52 enrolled 19 charts